Evidence map›Paper›PMID 34103408›Full record

ArticleScience translational medicine2021

Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.

Miguel Reyes, Michael R Filbin, Roby P Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, Kyle R Kays, Mayra Pinilla-Vera, Maura E Benson, Lisa A Cosimi and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Science translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 2 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in immunology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Miguel ReyesBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-2776-0862
Michael R FilbinBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-2588-7504
Roby P BhattacharyyaBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0001-6955-5088
Abraham SonnyDepartment of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-2101-9849
Arnav MehtaBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-0313-2848
Kianna BillmanBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0001-5675-3309
Kyle R KaysDepartment of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Mayra Pinilla-VeraDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Maura E BensonDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5481-4638
Lisa A CosimiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5269-1881
Deborah T HungBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-4262-0673
Bruce D LevyDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-9515-5731
Alexandra-Chloe VillaniBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0001-7461-0408
Moshe Sade-FeldmanBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-0022-0287
Rebecca M BaronDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1673-9523
Marcia B GoldbergBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-4266-9733
Paul C BlaineyBroad Institute of MIT and Harvard, Cambridge, MA, USA. pblainey@broadinstitute.org nhacohen@broadinstitute.org.ORCID 0000-0002-4889-8783
Nir HacohenBroad Institute of MIT and Harvard, Cambridge, MA, USA. pblainey@broadinstitute.org nhacohen@broadinstitute.org.ORCID 0000-0002-2349-2656
Broad Institute · USBrigham and Women's Hospital · USHarvard University · US

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Research Training for AnesthetistsT32GM007592 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STUART A FORMAN · 1985 to 2026
$11.8M
Single-cell genomic profiling to identify immune signatures of bacterial sepsis in humansR01AI153142 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FILBIN, MICHAEL, GOLDBERG, MARCIA B · 2021 to 2025
$5.0M
Therapeutic modulation of zinc for lung injury and mechanobiologyR01HL142093 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BARON, REBECCA M, TSCHUMPERLIN, DANIEL J. · 2019 to 2022
$2.8M
The Immune Cell Atlas – A Robust Framework to Map the Entire Human Immune SystemR56AI137244 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENOIST, CHRISTOPHE O., HACOHEN, NIR · 2018 to 2018
$2.0M
Low-input multiplex isolation and profiling of human immune cell subsets using an integrated microfluidics deviceU24AI118668 · NIAID · BROAD INSTITUTE, INC. · PI HACOHEN, NIR · 2015 to 2019
$2.0M
Bioinformatic and functional analysis of antibiotic-responsive small non-coding RNAs in bacterial pathogensK08AI119157 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BHATTACHARYYA, ROBY PAUL · 2015 to 2018
$758k
NIAID NIH HHS K08 AI119157NIAID NIH HHS R01 AI153142NIAID NIH HHS R56 AI137244NIAID NIH HHS U19 AI082630NIAID NIH HHS U24 AI118668NIGMS NIH HHS T32 GM007592NIH HHS 1K08 AI119157-04
6 · The paper itself

Abstract

Bacterial sepsis and severe COVID-19 share similar clinical manifestations and are both associated with dysregulation of the myeloid cell compartment. We previously reported an expanded CD14

Indexed as

COVID-19Hematopoietic Stem Cell TransplantationSepsisHumansMyeloid CellsSARS-CoV-2

Identifiers

PMID34103408
PMCPMC8432955
OpenAlexW3170939617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.